Key result
Anticoagulation linked to reduced intracardiac renal tumor thrombus size without thromboembolism at 12 weeks.
Why the study?
Renal cell carcinoma can be associated with tumor thrombus extending into the inferior vena cava and right atrium, representing a risk of massive pulmonary embolism.
Does medical management with anticoagulation reduce the risk of tumor thrombus extension or thromboembolism in patients with extensive intracardiac renal cell tumor thrombus unsuitable for surgical extraction?
Case Report (n=1)
Does medical management with anticoagulation reduce the risk of tumor thrombus extension or thromboembolism in patients with extensive intracardiac renal cell tumor thrombus unsuitable for surgical extraction?
Medical management with anticoagulation may be a viable option for extensive intracardiac renal cell tumor thrombus when surgical extraction is unsuitable, potentially leading to thrombus organization and reduced thromboembolic risk.
May support anticoagulation for select intracardiac tumor thrombi; leaves open whether this alters surgical indications in renal cell carcinoma.
BACKGROUND: Renal cell carcinoma is associated with tumor thrombus that can extend into the inferior vena cava and right atrium, representing risk of massive pulmonary embolism. CASE SUMMARY: A 60-year-old woman was diagnosed with renal cell carcinoma. Computed tomography imaging demonstrated a heterogeneous mass extending from the right renal vein into the right ventricle in keeping with tumor thrombus. On transthoracic echocardiogram, the tumor thrombus can be seen to prolapse into the right ventricle with diastole. Surgical extraction was discussed but ultimately not performed. At 6 weeks post diagnosis, the tumor thrombus had organized and become more homogeneous. At 12 weeks post diagnosis, the patient remained well without signs of thromboembolism. DISCUSSION: We present a case of increasing organization and size reduction of medically managed extensive renal cell tumor thrombus on interval echocardiography. TAKE-HOME MESSAGE: In cases in which surgical extraction is unsuitable, risk of tumor thrombus extension or thromboembolism may reduce with anticoagulation.
No takes yet. Share an insight, caveat, or question.
Courcy et al. (2026) conducted a case report in Renal cell carcinoma with extensive intracardiac tumor thrombus (n=1). Medical management (anticoagulation) was evaluated on Tumor thrombus organization and signs of thromboembolism. Medical management with anticoagulation of an extensive intracardiac renal cell tumor thrombus resulted in increasing organization and size reduction without thromboembolism at 12 weeks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: